Silver Book Fact

From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical life-year.

The Expanding Pharmaceutical Arsenal in the War on Cancer. NBER Working Paper Series Web site. http://www.nber.org/papers/w10328. Published 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
NBER Working Paper Series
Publication Date
Published 2004
Authors
Lichtenberg F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Over the next 10 years, the number of cancer survivors in the U.S. is predicted to grow from 14.5 million to nearly 19 million (9.3 million men and 9.6 million…  
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
  • A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.  
  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.